Roberto Manfredi, Sergio Sabbatani. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAntiviral Agents/therapeutic useFilgrastimGenotypeGranulocyte Colony-Stimulating Factor/administration & dosageGranulocyte Colony-Stimulating Factor/therapeutic useHepacivirus/geneticsHepacivirus/metabolismHepatitis C/drug therapyHumansInterferon alpha-2Interferon-alpha/adverse effectsMaleNeutropenia/chemically inducedNeutropenia/drug therapyPolyethylene Glycols/adverse effectsRecombinant ProteinsRecurrenceRibavirin/therapeutic useTreatment Outcome
Substances： See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsGranulocyte Colony-Stimulating FactorPolyethylene GlycolsRibavirinFilgrastimpeginterferon alfa-2a
Year: 2007 PMID： 18019674
Source DB: PubMed Journal: Hepatogastroenterology ISSN： 0172-6390